Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marcus Wiemer

Showing results (71-80 of 96) with videos related to

Pageof 10
Sort By:
Cardiovascular Diabetology|February 11, 2017
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-upMarcus Wiemer, Sinisa Stoikovic, Alexander Samol, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialPatrick W Serruys, Andrew T L Ong, Jan J Piek, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 7, 2010
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II studyYoshinobu Onuma, Shuzou Tanimoto, Peter Ruygrok, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)Keiichi Tsuchida, Jan J Piek, Franz-Josef Neumann, et al.
Cardiovascular Diabetology|May 6, 2017
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-upMarcus Wiemer, Sinisa Stojkovic, Alexander Samol, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 20, 2025
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I studyMichael Haude, Adrian Wlodarczak, René J van der Schaaf, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 30, 2018
Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trialChristoph J Jensen, Gert Richardt, Ralph Tölg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesionsStefan Verheye, Steve Ramcharitar, Eberhard Grube, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 27, 2012
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 studyGian Battista Danzi, Bernard Chevalier, Philip Urban, et al.
Heart (British Cardiac Society)|August 12, 2016
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patientsGian Battista Danzi, Raffaele Piccolo, Bernard Chevalier, et al.
Pageof 10

Showing results (71-80 of 96) with videos related to

Sort By:
Pageof 10
Cardiovascular Diabetology|February 11, 2017
Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-upMarcus Wiemer, Sinisa Stoikovic, Alexander Samol, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trialPatrick W Serruys, Andrew T L Ong, Jan J Piek, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|August 7, 2010
Efficacy of everolimus eluting stent implantation in patients with calcified coronary culprit lesions: two-year angiographic and three-year clinical results from the SPIRIT II studyYoshinobu Onuma, Shuzou Tanimoto, Peter Ruygrok, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 18, 2009
One-year results of a durable polymer everolimus-eluting stent in de novo coronary narrowings (The SPIRIT FIRST Trial)Keiichi Tsuchida, Jan J Piek, Franz-Josef Neumann, et al.
Cardiovascular Diabetology|May 6, 2017
Erratum to: Third generation drug eluting stent (DES) with biodegradable polymer in diabetic patients: 5 years follow-upMarcus Wiemer, Sinisa Stojkovic, Alexander Samol, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 20, 2025
Clinical outcomes of the third-generation resorbable magnesium scaffold for coronary artery lesions: three-year results of the BIOMAG-I studyMichael Haude, Adrian Wlodarczak, René J van der Schaaf, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 30, 2018
Angiographic and clinical performance of a paclitaxel-coated balloon compared to a second-generation sirolimus-eluting stent in patients with in-stent restenosis: the BIOLUX randomised controlled trialChristoph J Jensen, Gert Richardt, Ralph Tölg, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|September 21, 2011
Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesionsStefan Verheye, Steve Ramcharitar, Eberhard Grube, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|January 27, 2012
Clinical performance of a drug-eluting stent with a biodegradable polymer in an unselected patient population: the NOBORI 2 studyGian Battista Danzi, Bernard Chevalier, Philip Urban, et al.
Heart (British Cardiac Society)|August 12, 2016
Five-year clinical performance of a biodegradable polymer-coated biolimus-eluting stent in unselected patientsGian Battista Danzi, Raffaele Piccolo, Bernard Chevalier, et al.
Pageof 10